Brickell Biotech (BBI)

Brickell Biotech Financial Statements

Brickell Biotech Financial Overview

Brickell Biotech's market cap is currently ―. The company's EPS TTM is $-13.658; its P/E ratio is -0.25; Brickell Biotech is scheduled to report earnings on November 17, 2022, and the estimated EPS forecast is $-1.68. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 92.00K$ 104.00K$ 132.00K$ 151.00K$ 17.00K
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -9.41M$ -6.06M$ -13.25M$ -11.12M$ -8.97M
EBITDA$ -9.40M$ -6.06M$ -13.24M$ -11.11M$ -8.97M
Net Income Common Stockholders$ -9.41M$ -6.07M$ -13.25M$ -11.15M$ -9.01M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 17.29M$ 20.17M$ 21.38M$ 24.41M$ 26.88M
Total Assets$ 20.79M$ 29.72M$ 24.19M$ 29.07M$ 38.85M
Total Debt$ 68.00K$ 89.00K$ 201.00K$ 246.00K$ 489.00K
Net Debt$ -17.22M$ -20.09M$ -21.18M$ -24.16M$ -26.39M
Total Liabilities$ 4.74M$ 4.81M$ 4.22M$ 6.72M$ 9.71M
Stockholders Equity$ 16.05M$ 18.71M$ 19.97M$ 22.35M$ 24.91M
Cash Flow
Free Cash Flow$ -9.54M$ -4.80M$ -11.14M$ -14.31M$ -5.93M
Operating Cash Flow$ -9.54M$ -4.80M$ -11.14M$ -14.31M$ -5.89M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 4.00K$ -40.00K
Financing Cash Flow$ -55.00K$ 10.30M$ 8.12M$ 3.94M$ 10.60M
Currency in USD

Brickell Biotech Earnings and Revenue History

Brickell Biotech Debt to Assets

Brickell Biotech Cash Flow

Brickell Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis